Remember everyone, HemaXellerate is under the watchful eye of many BP's. How do I know this? Well, I just do. ; - ) As many of you already know, tis my job (that one I plan to retire from in the very near future btw) to know the inner workings and current status of marketed pharmaceuticals. Since I am a nosy woman that is more than proficient at research and connecting the dots, if I say so myself, I have successfully logged into this wee brain of mine a plethora of information so detailed that if Koos hired me today, he would feel compelled to laminate that Regen DD of the Year Award and present it to me before crying at the rays of sunshine radiating from that contract with the BP he just signed. Tee, hee, hee.
Enough with the self aggrandizing.
There have been some major plays with the Regen team of late. A lot has happened in a very short period of time. It is not a coincidence that David Koos submitted that preliminary filing to increase the A/S (an increase that is very unlikely to happen. At least to that extent.) outlining the details of the purchase price for the Min Technology--you know, that little invention that silences genes... can you say cha-cha-cha-ching $$$?-- almost hurriedly it would seem based on the typo's that are out-of-character for Koos--and the completion of the patent trademark for Hema was published. Believe you me, they did not pay all the associated fees for trademarking and protecting every aspect of Hema if they were not certain it was soon to be found in a clinical trials near you. Nor would they go to the great lengths they have (and they are great) if they weren't pretty darn convinced the treatment is going to be successful in human trials. Or, perhaps especially even, the great lengths gone to if they weren't 100% confident in the Min science.
If you consider all of the minds associated with BMSN & ENTB and remember that they do all work together, you will have no other choice but to conclude that your money is invested in a team of doctors that have done nothing but get things done in the world of medicine!
PG predicts that when we get the much anticipated PR we are going to be awed by what we are reading. It will all be over but the crying for those fools that flipped for a few hundred or were of little faith and jumped ship.
Remember, the business of Pharma is a lot like the business of politics; when they want to know something, they want to know it now and are willing to pay for it. When they do, the info had better be something they can work with. Otherwise, they have no use for you and you might as well take your place in the long line of has-been's.
I have pointed this out before. Just asking you to keep in mind that Hema is not on this list because Fast Market Research needed a filler.
Will today be the day? BMSN!
